Shozo Sueda Selected Research

Shozo Sueda Research Topics

Disease

50	Spasm (Spasms) 09/2022 - 06/2002
11	Chest Pain (Chest Pains) 06/2022 - 09/2002
9	Coronary Vasospasm (Coronary Artery Vasospasm) 06/2021 - 09/2003
8	Muscle Spasticity (Spastic) 06/2020 - 02/2003
6	Coronary Artery Disease (Coronary Atherosclerosis) 09/2022 - 05/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
5	Pathologic Constriction (Stenosis) 01/2022 - 02/2003
4	Ventricular Fibrillation 06/2022 - 01/2014
4	Shock 01/2022 - 01/2007
3	Myocardial Infarction 01/2022 - 09/2010
3	Unstable Angina 01/2022 - 01/2014
3	Death (Near-Death Experience) 01/2022 - 09/2010
3	Heart Failure 01/2022 - 09/2010
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2020 - 05/2018
2	Dyslipidemias (Dyslipidemia) 01/2022 - 08/2020
2	Hypertension (High Blood Pressure) 01/2022 - 08/2020
2	Coronary Stenosis (Coronary Artery Stenosis) 10/2021 - 12/2019
2	Acute Coronary Syndrome 01/2014 - 01/2007
1	Asthma (Bronchial Asthma) 12/2020
1	Burns 03/2020
1	Disease Progression 01/2020
1	Hyperventilation 01/2020
1	Ischemia 12/2019
1	Diabetes Mellitus 01/2019
1	Bradycardia 01/2019
1	Heart Diseases (Heart Disease) 05/2018
1	Fatigue 06/2015
1	Stroke (Strokes) 09/2010
1	Aortic Aneurysm (Aneurysm, Aortic) 09/2010
1	Rupture 12/2009
1	Cardiac Tamponade 04/2008
1	Ventricular Tachycardia 04/2008
1	Atrial Fibrillation 04/2008
1	Hypovolemia 04/2008
1	Insulin Resistance 09/2004
1	Essential Hypertension 09/2004
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2003
1	Angina Pectoris 07/2003
1	Hyperemia 07/2003

Drug/Important Bio-Agent (IBA)

35	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2022 - 06/2002
19	Ergonovine (Ergometrine)IBA 06/2022 - 09/2003
13	Phenobarbital (Luminal)FDA Link 12/2020 - 06/2002
5	Vasodilator Agents (Vasodilators)IBA 06/2021 - 10/2003
5	omega-Chloroacetophenone (Mace)IBA 01/2019 - 09/2010
4	NitratesIBA 08/2020 - 01/2015
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 06/2015
3	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 02/2007 - 12/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 08/2020
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 08/2020
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 08/2020
2	Adenosine (Adenocard)FDA LinkGeneric 10/2021 - 12/2019
2	iodofiltic acidIBA 01/2020 - 02/2007
2	3-Iodobenzylguanidine (Iobenguane)IBA 01/2020 - 09/2004
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2008 - 01/2007
2	CalciumIBA 02/2007 - 02/2003
1	ThalliumIBA 10/2021
1	APTIBA 08/2020
1	Proton Pump InhibitorsIBA 03/2020
1	thallium chloride (thallous chloride)IBA 12/2019
1	LipidsIBA 12/2009
1	cifenline (cibenzoline)IBA 04/2008
1	Nicorandil (SG 75)IBA 02/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2007
1	Cholinergic Agents (Cholinergics)IBA 11/2005
1	Troglitazone (Rezulin)FDA Link 09/2004
1	Glucose (Dextrose)FDA LinkGeneric 09/2004
1	Betaxolol (Kerlon)FDA LinkGeneric 10/2003
1	Adrenergic Receptors (Adrenergic Receptor)IBA 10/2003
1	Adenosine Triphosphate (ATP)IBA 09/2003
1	Cilostazol (Pletal)FDA LinkGeneric 07/2003
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 07/2003
1	Arginine (L-Arginine)FDA Link 07/2003
1	Thromboxane A2 (A2, Thromboxane)IBA 09/2002
1	ozagrelIBA 09/2002
1	ThromboxanesIBA 09/2002

Therapy/Procedure

10	Therapeutics 12/2020 - 02/2003
6	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 05/2018
2	Percutaneous Coronary Intervention 06/2017 - 11/2005
1	Resuscitation 06/2022
1	Off-Label Use 12/2020
1	Catheters 01/2019
1	Stents 01/2007